PlainRecalls
FDA Drug Moderate Class II Ongoing

DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62

Reported: July 2, 2025 Initiated: May 28, 2025 #D-0489-2025

Product Description

DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62

Reason for Recall

Discoloration; discolored solution from cracked vials

Details

Recalling Firm
Pfizer Inc.
Units Affected
98,410 vials
Distribution
Nationwide in the USA
Location
New York, NY

Frequently Asked Questions

What product was recalled?
DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62. Recalled by Pfizer Inc.. Units affected: 98,410 vials.
Why was this product recalled?
Discoloration; discolored solution from cracked vials
Which agency issued this recall?
This recall was issued by the FDA Drug on July 2, 2025. Severity: Moderate. Recall number: D-0489-2025.